1. Home
  2. ARVN vs PD Comparison

ARVN vs PD Comparison

Compare ARVN & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • PD
  • Stock Information
  • Founded
  • ARVN 2015
  • PD 2009
  • Country
  • ARVN United States
  • PD United States
  • Employees
  • ARVN N/A
  • PD N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • PD Computer Software: Prepackaged Software
  • Sector
  • ARVN Health Care
  • PD Technology
  • Exchange
  • ARVN Nasdaq
  • PD Nasdaq
  • Market Cap
  • ARVN 1.8B
  • PD 1.8B
  • IPO Year
  • ARVN 2018
  • PD 2019
  • Fundamental
  • Price
  • ARVN $18.48
  • PD $18.47
  • Analyst Decision
  • ARVN Strong Buy
  • PD Buy
  • Analyst Count
  • ARVN 13
  • PD 11
  • Target Price
  • ARVN $63.00
  • PD $22.09
  • AVG Volume (30 Days)
  • ARVN 967.8K
  • PD 1.5M
  • Earning Date
  • ARVN 10-30-2024
  • PD 11-26-2024
  • Dividend Yield
  • ARVN N/A
  • PD N/A
  • EPS Growth
  • ARVN N/A
  • PD N/A
  • EPS
  • ARVN N/A
  • PD N/A
  • Revenue
  • ARVN $161,100,000.00
  • PD $457,170,000.00
  • Revenue This Year
  • ARVN $237.44
  • PD $11.37
  • Revenue Next Year
  • ARVN N/A
  • PD $10.02
  • P/E Ratio
  • ARVN N/A
  • PD N/A
  • Revenue Growth
  • ARVN 1.07
  • PD 8.71
  • 52 Week Low
  • ARVN $17.37
  • PD $16.46
  • 52 Week High
  • ARVN $53.08
  • PD $26.70
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 32.78
  • PD 33.95
  • Support Level
  • ARVN $17.37
  • PD $19.84
  • Resistance Level
  • ARVN $19.21
  • PD $20.57
  • Average True Range (ATR)
  • ARVN 1.64
  • PD 0.69
  • MACD
  • ARVN -0.59
  • PD -0.33
  • Stochastic Oscillator
  • ARVN 11.80
  • PD 3.59

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its platform harnesses digital signals from virtually any software-enabled system or device and combines it with human response data to take the right actions in real-time. The product offerings of the company include PagerDuty Incident Management, DevOps, AIOPs, Process Automation, and Customer Service Operations.

Share on Social Networks: